Ticker
BDSXCompany Name
BIODESIX INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 87.74M | $ 20.73M | 23.62% |
3/31/2025 | $ 86.24M | $ 17.6M | 20.41% |
12/31/2024 | $ 97.24M | $ 26.25M | 26.99% |
9/30/2024 | $ 102.74M | $ 31.41M | 30.57% |
6/30/2024 | $ 115.84M | $ 42.22M | 36.45% |
3/31/2024 | $ 87.2M | $ 11.49M | 13.18% |
12/31/2023 | $ 99.1M | $ 26.28M | 26.52% |
9/30/2023 | $ 86.79M | $ 19.84M | 22.86% |
6/30/2023 | $ 77.62M | $ 17.41M | 22.43% |
3/31/2023 | $ 80.79M | $ 25.27M | 31.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for BIODESIX INC is calculated as follows: CashnEq [ $ 5.29M ] / Assets [ $ 41.63M ]
(=) Cash to Assets [ 12.7% ]
Minimum
Dec 31, 2019
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |